---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-234391"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2024-10-08T23:59:59+00:00"
generated_at: "2026-05-30T18:06:30.250609+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Verrica out of Nasdaq compliance after director resignation; cure period granted

## Summary
- Craig Ballaron resigned from Board effective October 2, 2024.
- Board appointed Diem Nguyen to Audit Committee on October 7, 2024.
- Resignation caused loss of majority independent directors, violating Nasdaq Rule 5605(b)(1).
- Nasdaq provided cure period until next annual meeting or October 2, 2025.
- Company expects to regain compliance within the cure period.

## SEC filing metadata
- accession: 0001193125-24-234391
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2024-10-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312524234391/0001193125-24-234391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524234391/d796842d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-234391
- JSON: https://secwatch.observer/filing/0001193125-24-234391.json
- Plain text: https://secwatch.observer/filing/0001193125-24-234391.txt

## Key facts
- Executive change
  Craig Ballaron resigned as member of the Board of Directors at Verrica Pharmaceuticals Inc..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On October 2, 2024, Craig Ballaron, a member of the Board of Directors (the “Board ”) of Verrica Pharmaceuticals Inc. (the “ Company ”), notified the Company that he was resigning from the Board and all committees of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312524234391/0001193125-24-234391-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.